Details for New Drug Application (NDA): 021375
✉ Email this page to a colleague
The generic ingredient in ALAVERT is loratadine. There are thirty-nine drug master file entries for this compound. One hundred and fifty suppliers are listed for this compound. Additional details are available on the loratadine profile page.
Summary for 021375
Tradename: | ALAVERT |
Applicant: | Fdn Consumer |
Ingredient: | loratadine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 021375
Suppliers and Packaging for NDA: 021375
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALAVERT | loratadine | TABLET, ORALLY DISINTEGRATING;ORAL | 021375 | NDA | Haleon US Holdings LLC | 0573-2620 | 0573-2620-01 | 50 POUCH in 1 BOX (0573-2620-01) / 1 TABLET, ORALLY DISINTEGRATING in 1 POUCH |
ALAVERT | loratadine | TABLET, ORALLY DISINTEGRATING;ORAL | 021375 | NDA | Haleon US Holdings LLC | 0573-2620 | 0573-2620-19 | 18 BLISTER PACK in 1 CARTON (0573-2620-19) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 10MG | ||||
Approval Date: | Dec 19, 2002 | TE: | RLD: | No |
Complete Access Available with Subscription